Drug Profile
INKmune - INmune Bio
Alternative Names: INB 16; INKmuneLatest Information Update: 03 Apr 2024
Price :
$50
*
At a glance
- Originator INmune Bio
- Class Antineoplastics; Immunotherapies; Natural killer cell therapies
- Mechanism of Action Immunologic cytotoxicity; Natural killer cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Prostate cancer
- Phase I Acute myeloid leukaemia; Myelodysplastic syndromes; Ovarian cancer
- Preclinical Renal cancer